HIV

/Tag:HIV

Strategic Partnership Announcement: Atomo Diagnostics and Access Bio

Today, Atomo Diagnostics and Access Bio Inc. jointly announced a strategic partnership to leverage the respective strengths of both companies and expand point of care HIV testing in global markets. [...]

January 23rd, 2018|

Atomo Diagnostics and Access Bio partner to expand access to best-in-class HIV rapid testing in global markets

Sydney, Australia and Seoul, South Korea – 23 January 2018 | Atomo Diagnostics and Access Bio Inc. today announce a strategic partnership to leverage the respective strengths of both innovative [...]

January 23rd, 2018|

Atomo HIV Self Test approved by Expert Review Panel

Atomo Diagnostics' CEO, John Kelly, today announced that the Atomo HIV Self Test has been approved by the World Health Organisation’s Expert Review Panel for Diagnostics (ERP-D); a special process determined [...]

December 6th, 2017|

PRESS RELEASE: Expert Review Panel for Diagnostics approves Atomo HIV Self Test for procurement by Unitaid and the Global Fund

Sydney, Australia, 7 December 2017 | Atomo Diagnostics, the world leader in integrated point-of-care rapid diagnostic devices, announced today that its Atomo HIV Self Test has been confirmed as eligible [...]

December 6th, 2017|

World AIDS Day 2017: Self-testing key to improving early diagnosis of HIV

Written by CEO, John Kelly: As I read the news, on this World AIDS Day, I am heartened to see so many positive and inspiring stories about the progress being [...]

December 1st, 2017|

SAHIVSoc publishes Clinical Guidelines for HIV Self-Testing

Written by John Kelly, CEO at Atomo Diagnostics: The Southern African HIV Clinicians Society (SAHIVSoc) has recently published it's clinical guidelines for HIV self-testing to support achieving the first '90' of [...]

June 19th, 2017|

Atomo Diagnostics’ HIV Self Test receives approval from Kenya Ministry of Health

Sydney, Australia, May 30, 2017| Multi-award winning medical device innovator Atomo Diagnostics today announced its pioneering HIV self test product has been approved for sale in Kenya. Following successful product [...]

May 30th, 2017|

Canadian Government Fund Invests in Atomo

Delighted to welcome new investors for 2017, earlier this month Atomo Diagnostics announced backing from Grand Challenges Canada (GCC). Investment from the Canadian Government-funded agency totalling US$1 million (A$1.31 million, [...]

February 20th, 2017|

Atomo Diagnostics receives further international financing

SYDNEY, Australia, 1 February  2017: Medical device innovator Atomo Diagnostics today announced it had received US$1 million (A$1.31 million, C$1.32 million) in financing from Grand Challenges Canada to support its continued [...]

February 1st, 2017|

AtomoRapid featured in latest issue of Australian Biochemist

The December issue of Australian Biochemist is out and Atomo Diagnostics is highlighted in its Special Technical Feature on microfluidics and molecular diagnostic technologies that have revolutionised testing for infectious [...]

December 23rd, 2016|